vs
Side-by-side financial comparison of DYNEX CAPITAL INC (DX) and MEDIFAST INC (MED). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $43.5M, roughly 1.7× DYNEX CAPITAL INC). On growth, DYNEX CAPITAL INC posted the faster year-over-year revenue change (531.3% vs -36.9%). Over the past eight quarters, DYNEX CAPITAL INC's revenue compounded faster (75.8% CAGR vs -34.4%).
Dynex Capital Inc. is a publicly traded real estate investment trust headquartered in the United States. It specializes in investing in and managing a diversified portfolio of mortgage-backed securities, residential and commercial mortgage loans, and other mortgage-related assets. It delivers consistent returns to shareholders via regular dividends and long-term capital growth.
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
DX vs MED — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.5M | $75.1M |
| Net Profit | — | — |
| Gross Margin | — | 69.4% |
| Operating Margin | — | -10.4% |
| Net Margin | — | — |
| Revenue YoY | 531.3% | -36.9% |
| Net Profit YoY | — | — |
| EPS (diluted) | $1.59 | $-1.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.5M | $75.1M | ||
| Q3 25 | $30.6M | $89.4M | ||
| Q2 25 | $23.1M | $105.6M | ||
| Q1 25 | $17.1M | $115.7M | ||
| Q4 24 | — | $119.0M | ||
| Q3 24 | — | $140.2M | ||
| Q2 24 | — | $168.6M | ||
| Q1 24 | $-3.2M | $174.7M |
| Q4 25 | — | — | ||
| Q3 25 | $150.4M | $-2.3M | ||
| Q2 25 | $-13.6M | $2.5M | ||
| Q1 25 | $-3.1M | $-772.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.1M | ||
| Q2 24 | — | $-8.2M | ||
| Q1 24 | $40.1M | $8.3M |
| Q4 25 | — | 69.4% | ||
| Q3 25 | — | 69.5% | ||
| Q2 25 | — | 72.6% | ||
| Q1 25 | — | 72.8% | ||
| Q4 24 | — | 74.1% | ||
| Q3 24 | — | 75.4% | ||
| Q2 24 | — | 73.2% | ||
| Q1 24 | — | 72.8% |
| Q4 25 | — | -10.4% | ||
| Q3 25 | — | -4.6% | ||
| Q2 25 | — | -1.0% | ||
| Q1 25 | — | -1.1% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | -4.7% | ||
| Q1 24 | — | 4.5% |
| Q4 25 | — | — | ||
| Q3 25 | 491.3% | -2.5% | ||
| Q2 25 | -58.8% | 2.3% | ||
| Q1 25 | -18.0% | -0.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | -4.8% | ||
| Q1 24 | -1256.8% | 4.8% |
| Q4 25 | $1.59 | $-1.64 | ||
| Q3 25 | $1.08 | $-0.21 | ||
| Q2 25 | $-0.14 | $0.22 | ||
| Q1 25 | $-0.06 | $-0.07 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | — | $-0.75 | ||
| Q1 24 | $0.64 | $0.76 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $531.0M | $167.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.5B | $198.9M |
| Total Assets | $17.3B | $248.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $531.0M | $167.3M | ||
| Q3 25 | $491.0M | $173.5M | ||
| Q2 25 | $387.5M | $162.7M | ||
| Q1 25 | $327.4M | $164.6M | ||
| Q4 24 | — | $162.3M | ||
| Q3 24 | — | $170.0M | ||
| Q2 24 | — | $163.5M | ||
| Q1 24 | $295.7M | $156.4M |
| Q4 25 | $2.5B | $198.9M | ||
| Q3 25 | $2.0B | $214.7M | ||
| Q2 25 | $1.6B | $216.0M | ||
| Q1 25 | $1.4B | $211.0M | ||
| Q4 24 | — | $210.1M | ||
| Q3 24 | — | $207.3M | ||
| Q2 24 | — | $205.3M | ||
| Q1 24 | $958.5M | $211.0M |
| Q4 25 | $17.3B | $248.0M | ||
| Q3 25 | $14.2B | $268.2M | ||
| Q2 25 | $11.3B | $269.3M | ||
| Q1 25 | $9.0B | $280.0M | ||
| Q4 24 | — | $284.2M | ||
| Q3 24 | — | $291.2M | ||
| Q2 24 | — | $293.5M | ||
| Q1 24 | $6.3B | $302.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $120.8M | $-5.3M |
| Free Cash FlowOCF − Capex | — | $-6.6M |
| FCF MarginFCF / Revenue | — | -8.8% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $120.8M | $-5.3M | ||
| Q3 25 | $68.3M | $12.1M | ||
| Q2 25 | $31.9M | $-3.4M | ||
| Q1 25 | $6.4M | $3.4M | ||
| Q4 24 | — | $-4.9M | ||
| Q3 24 | — | $9.1M | ||
| Q2 24 | — | $13.1M | ||
| Q1 24 | $-17.1M | $7.3M |
| Q4 25 | — | $-6.6M | ||
| Q3 25 | — | $10.8M | ||
| Q2 25 | — | $-4.8M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $-7.2M | ||
| Q3 24 | — | $7.7M | ||
| Q2 24 | — | $11.1M | ||
| Q1 24 | — | $5.4M |
| Q4 25 | — | -8.8% | ||
| Q3 25 | — | 12.0% | ||
| Q2 25 | — | -4.5% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | — | -6.1% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 3.1% |
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.3% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | — | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | — | -1.36× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 8.04× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.43× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
